Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Zeevalk

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Amino Acids|January 1, 1999
Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonismP K Sonsalla, D S Albers, G D Zeevalk
Journal of Neurochemistry|January 1, 1995
NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acidG D Zeevalk, E Derr-Yellin, W J Nicklas
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2001
Differential sensitivity of mesencephalic neurons to inhibition of phosphatase 2AG D Zeevalk, L P Bernard, L Manzino, et al.
Experimental Neurology|October 20, 2006
Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: relevance to Parkinson's diseaseG D Zeevalk, L Manzino, P K Sonsalla, et al.
Journal of Neurochemistry|December 1, 1998
Origins of the extracellular glutamate released during total metabolic blockade in the immature retinaG D Zeevalk, N Davis, A G Hyndman, et al.
Antioxidants & Redox Signaling|August 24, 2005
Mitochondrial inhibition and oxidative stress: reciprocating players in neurodegenerationG D Zeevalk, L P Bernard, C Song, et al.
Brain Research|October 11, 1991
Transferrin can alter physiological properties of retinal neuronsA G Hyndman, P E Hockberger, G D Zeevalk, et al.
Journal of Neuroscience Research|March 29, 2001
Attenuation of malonate toxicity in primary mesencephalic cultures using the GABA transport blocker, NO-711A H Stokes, L P Bernard, W J Nicklas, et al.
Journal of Neurochemistry|May 1, 1992
MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in ratsP K Sonsalla, G D Zeevalk, L Manzino, et al.
Developmental Neuroscience|October 21, 1998
Excitotoxicity and oxidative stress during inhibition of energy metabolismG D Zeevalk, L P Bernard, C Sinha, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Amino Acids|January 1, 1999
Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonismP K Sonsalla, D S Albers, G D Zeevalk
Journal of Neurochemistry|January 1, 1995
NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acidG D Zeevalk, E Derr-Yellin, W J Nicklas
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2001
Differential sensitivity of mesencephalic neurons to inhibition of phosphatase 2AG D Zeevalk, L P Bernard, L Manzino, et al.
Experimental Neurology|October 20, 2006
Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: relevance to Parkinson's diseaseG D Zeevalk, L Manzino, P K Sonsalla, et al.
Journal of Neurochemistry|December 1, 1998
Origins of the extracellular glutamate released during total metabolic blockade in the immature retinaG D Zeevalk, N Davis, A G Hyndman, et al.
Antioxidants & Redox Signaling|August 24, 2005
Mitochondrial inhibition and oxidative stress: reciprocating players in neurodegenerationG D Zeevalk, L P Bernard, C Song, et al.
Brain Research|October 11, 1991
Transferrin can alter physiological properties of retinal neuronsA G Hyndman, P E Hockberger, G D Zeevalk, et al.
Journal of Neuroscience Research|March 29, 2001
Attenuation of malonate toxicity in primary mesencephalic cultures using the GABA transport blocker, NO-711A H Stokes, L P Bernard, W J Nicklas, et al.
Journal of Neurochemistry|May 1, 1992
MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in ratsP K Sonsalla, G D Zeevalk, L Manzino, et al.
Developmental Neuroscience|October 21, 1998
Excitotoxicity and oxidative stress during inhibition of energy metabolismG D Zeevalk, L P Bernard, C Sinha, et al.
Pageof 5